市场调查报告书
商品编码
1390658
人类增强市场:2023-2028 年全球产业趋势、份额、规模、成长、机会与预测Human Enhancement Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球人类增强市场规模达到979亿美元。展望未来, IMARC Group预计到2028年市场规模将达到2,159亿美元,2022-2028年复合年增长率(CAGR)为14.09%。
人类增强是指对身体进行自然的、人工的和技术的改变,以增强个体的认知和身体能力和功能。它透过药物、荷尔蒙、植入物、基因工程、膳食补充剂和整容手术来进行自我完善。如今,人类增强技术的进步提供了对疟疾、结核病和莱姆病等疾病的抵抗力。它们还允许最新的诊断和基因组编辑技术的进步,例如用于人类免疫缺陷病毒(HIV)感染的功能性治癒的成簇规则间隔短回文重复序列(CRISPR)。
急性和慢性疾病的日益流行,以及医疗保健服务的日益普及,是积极影响全球人类增强技术需求的关键因素之一。这些技术主要包括奈米技术、资讯科技(IT)和认知科学,有助于升级生物医学介入措施以及诊断和治疗各种疾病。它们还包括主动控制系统,有助于创造具有超越人类表现特征的肢体义肢。此外,基因工程、神经元植入、脑机介面和三维(3D)生物列印等新兴技术也促进了市场的成长。除此之外,由于国家之间地缘政治紧张局势加剧,一些国家的安全机构正在投资研究项目,以提高战场表现。例如,法国陆军的伦理委员会批准了用于培养增强型士兵的人体增强技术的研究。这项研究还涉及利用从药物到外骨骼等先进系统来增强军事人员的目标决策能力。预计这些因素将推动人类增强技术的采用,并对未来几年的市场产生积极影响。
The global human enhancement market size reached US$ 97.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 215.9 Billion by 2028, exhibiting a growth rate (CAGR) of 14.09% during 2022-2028.
Human enhancement refers to a natural, artificial, and technological alteration of the body to enhance cognitive and physical capabilities and functions of individuals. It is undertaken using drugs, hormones, implants, genetic engineering to dietary supplements and cosmetic surgeries for self-improvement. Nowadays, advances in human enhancement technologies provide resistance against diseases like malaria, tuberculosis, and Lyme. They also allow up-to-date diagnostic and advancements in genome editing technologies, such as clustered regularly interspaced short palindromic repeats (CRISPR) for a functional cure of human immunodeficiency virus (HIV) infection.
The growing prevalence of acute and chronic diseases, in confluence with the increasing access to healthcare services, represents one of the key factors positively influencing the demand for human enhancement technologies around the world. These technologies mainly include nanotechnology, information technology (IT), and cognitive science, which assist in upgrading biomedical interventions as well as diagnose and treat various diseases. They also comprise active control systems that help create limb prosthetics with characteristics that exceed human performance. Moreover, emerging technologies like genetic engineering, neuronal implants, brain-computer interfaces, and three-dimensional (3D) bioprinting are contributing to the market growth. Apart from this, due to rising geopolitical tension between countries, security agencies of several countries are investing in research programs to improve battlefield performance. For instance, the ethics committee in the French Army approved the research of human enhancement technologies for developing enhanced soldiers. This research also involves the utilization of advanced systems, ranging from drugs to exoskeletons, to enhance military personnel in targeting decisions. These factors are anticipated to drive the adoption of human enhancement technologies and influence the market positively in the coming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global human enhancement market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, device type and end user.
Exoskeleton
Smart Devices
Medical Devices
Implants
Others
Body Worn
Non-Body Worn
Healthcare
Defense
Information Technology
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being BrainGate, B-Temia Inc, Ekso Bionics, Google LLC, Magic Leap Inc, Raytheon Technologies Corporation, ReWalk Robotics Ltd, Samsung Electronics Co. Ltd., Second Sight Medical Products Inc. and Vuzix Corporation.